Crestline Management, L.P.
CIK 0001536054
Annualised vol
20.324531%
Beta
0.080099
HHI
8479.83367
Top-10 weight
100.0%
VaR 95%
0.512397%
VaR 99%
4.015074%
Max drawdown
36.640783%
Matched value
96.831562%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| DNLI | REDUCED | DENALI THERAPEUTICS INC | COM | 24823R105 | 49,144,027 | 91.9 | 1910732.0 |
| SANA | UNCHANGED | SANA BIOTECHNOLOGY INC | COM | 799566104 | 2,637,619 | 4.93 | 755736.0 |
| - | 8X8 INC NEW | COM | 282914100 | 1,694,354 | 3.17 | 990850.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 534,760,000 | 3 | 20.324531 | 0.080099 | 36.640783 |
| 2026-03-31 | 2026-05-15 | 46,267,385 | 3 | 20.252617 | 0.079323 | 36.378777 |
| 2025-12-31 | 2026-02-17 | 53,326,374 | 3 | 20.163012 | 0.089344 | 39.353428 |
| 2025-09-30 | 2025-11-14 | 58,088,757 | 3 | 20.224074 | 0.093336 | 40.53227 |
| 2025-03-31 | 2025-05-15 | 63,235,626 | 3 | 20.266525 | 0.085555 | 38.267809 |
| 2024-12-31 | 2025-02-14 | 3,007,887,096 | 705 | 8.823997 | 0.41999 | 14.906644 |